Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16401486 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients
Condition: Chronic Hepatitis C
Interventions: Drug: Debio 025;   Drug: Peg-IFNα2a;   Drug: Ribavirin;   Drug: Debio 025 placebo

Indicates status has not been verified in more than two years